Glutathione IV Therapy FAQ's Glutathione IV therapy is beneficial for a wide range of individuals, particularly those with low glutathione levels due to factors like chronic stress, exposure to toxins, and aging
However, further extensive research is required to determine the advantages and potential risks
The wound healing cascade and GHK-Cu: Normal wound healing occurs in four overlapping phases: Hemostasis clotting Inflammation immune cell recruitment Proliferation new tissue formation Remodeling scar maturation GHK-Cu appears to favorably influence phases 2, 3, and 4 simultaneously: In the inflammatory phase , it reduces pro-inflammatory cytokines (IL-6, TNF-) while preserving necessary immune signaling In the proliferative phase , it stimulates keratinocyte migration and fibroblast proliferation, accelerating epithelial coverage In the remodeling phase , it promotes type I collagen deposition over type III (scar) collagen, leading to better scar outcomes This multi-phase tissue repair activity makes GHK-Cu a compound of interest when studied alongside other regenerative peptides
Health of the nervous system Glutathione has been studied for its potential neuroprotective effects
